Ignite Creation Date:
2024-05-06 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05328440
Status:
RECRUITING
Last Update Posted:
2023-09-25
First Post:
2022-03-14
Brief Title:
Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2 Advanced Breast CancerDAP-Her-02
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-14
First Submit QC Date:
April 13 2022
Study First Post Date:
2022-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-22
Last Update Post Date:
2023-09-25
Last Update Post Date Type:
ACTUAL